IL17D and neoplasm: Apart from O'Sullivan et al.’s observation that IL-117D mediates tumor rejection through recruitment of natural killer cells, Saddawi-Konefka et al. [28] also demonstrated that the transcription factor nuclear factor erythroid-derived 2-like 2 (Nrf2) could induce the expression of IL-17D in cancer cell lines.